Plain-English translation of NCT07039942 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The Omnipod 5 is an automated insulin pump system that works with a continuous blood sugar monitor to deliver insulin automatically throughout the day and night. This French study is following about 300 people with type 1 diabetes who have just started using this system to understand how well it works, how safe it is, and how it affects their daily lives over a full year.
While this automated insulin delivery system has been tested in clinical trials, doctors and patients want to know how well it actually works when people use it at home in their normal routines — not just in a controlled research setting. This study will help everyone understand the real benefits and how to support patients using this technology.
You will use the Omnipod 5 automated insulin pump system in your normal daily life for 12 months. During this time, you will stay in contact with your study site and answer questionnaires about how well your blood sugar is controlled, how the device is working for you, and how it affects your quality of life. The study does not require you to change how you use the pump — it simply tracks your real-world experience.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
France